P2Y12 Inhibitor-Based Monotherapy

被引：0
|
作者：
Choudhary, Rahul [1 ]
Deora, Surender [1 ]
机构：
[1] All India Inst Med Sci, Dept Cardiol, Jodhpur 342005, Rajasthan, India
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 76卷 / 10期
关键词：
TICAGRELOR; ASPIRIN;
D O I：
10.1016/j.jacc.2020.06.075
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1273 / 1274
页数：2
相关论文
共 50 条
  • [21] Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?
    Chandiramani, Rishi
    Mehta, Adhya
    Blumenthal, Roger S.
    Williams, Marlene S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (11) : 649 - 658
  • [22] P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
    Gragnano, Felice
    Mehran, Roxana
    Branca, Mattia
    Franzone, Anna
    Baber, Usman
    Jang, Yangsoo
    Kimura, Takeshi
    Hahn, Joo-Yong
    Zhao, Qiang
    Windecker, Stephan
    Gibson, Charles M.
    Kim, Byeong-Keuk
    Watanabe, Hirotoshi
    Bin Song, Young
    Zhu, Yunpeng
    Vranckx, Pascal
    Mehta, Shamir
    Hong, Sung-Jin
    Ando, Kenji
    Gwon, Hyeon-Cheol
    Calabro, Paolo
    Serruys, Patrick W.
    Dangas, George D.
    McFadden, Eugene P.
    Angiolillo, Dominick J.
    Heg, Dik
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (06) : 537 - 552
  • [23] Monotherapy with a P2Y12 inhibitor or aspirin for patients with established atherosclerosis: an updated meta-analysis
    Cannata, Francesco
    Chiarito, Mauro
    Sanz-Sanchez, Jorge
    Cao, Davide
    Sturla, Matteo
    Regazzoli, Damiano
    Reimers, Bernhard
    Condorelli, Gianluigi
    Ferrante, Giuseppe
    Stefanini, Giulio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [24] Monotherapy with a P2Y12 inhibitor or aspirin for patients with established atherosclerosis: an updated meta-analysis
    Cannata, Francesco
    Chiarito, Mauro
    Sanz-Sanchez, Jorge
    Cao, Davide
    Sturla, Matteo
    Regazzoli, Damiano
    Reimers, Bernhard
    Condorelli, Gianluigi
    Ferrante, Giuseppe
    Stefanini, Giulio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [25] P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    McCaw, Zachary R.
    Wei, Lee-Jen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (16): : 1607 - 1607
  • [26] P2Y12 inhibitor monotherapy is associated with superior outcomes as compared with aspirin monotherapy in chronic limb-threatening ischemia
    Khan, Sikandar Z.
    O'Brien-Irr, Monica S.
    Fakhoury, Elias
    Montross, Brittany
    Rivero, Mariel
    Dosluoglu, Hasan H.
    Harris, Linda M.
    Dryjski, Maciej L.
    JOURNAL OF VASCULAR SURGERY, 2022, 76 (04) : 1053 - 1059
  • [27] P2Y12 blocker monotherapy after percutaneous coronary intervention
    F. W. A. Verheugt
    P. Damman
    S. A. J. Damen
    J. J. Wykrzykowska
    E. C. I. Woelders
    R. -J. M. van Geuns
    Netherlands Heart Journal, 2021, 29 : 566 - 576
  • [28] P2Y12 blocker monotherapy after percutaneous coronary intervention
    Verheugt, F. W. A.
    Damman, P.
    Damen, S. A. J.
    Wykrzykowska, J. J.
    Woelders, E. C. I.
    van Geuns, R. -J. M.
    NETHERLANDS HEART JOURNAL, 2021, 29 (11) : 566 - 576
  • [29] Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor
    Dobesh, Paul P.
    PHARMACOTHERAPY, 2009, 29 (09): : 1089 - 1102
  • [30] P2Y12 INHIBITOR MONOTHERAPY OR DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH HYPERTENSION
    Pil-Sang, Song
    Jin-Ok, Jeong
    JOURNAL OF HYPERTENSION, 2023, 41 : E178 - E178
12345